159 related articles for article (PubMed ID: 7539263)
21. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).
Karsten U; Serttas N; Paulsen H; Danielczyk A; Goletz S
Glycobiology; 2004 Aug; 14(8):681-92. PubMed ID: 15115750
[TBL] [Abstract][Full Text] [Related]
22. Mucin glycoproteins as tumor markers.
Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
[TBL] [Abstract][Full Text] [Related]
23. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
Karsten U; Diotel C; Klich G; Paulsen H; Goletz S; Müller S; Hanisch FG
Cancer Res; 1998 Jun; 58(12):2541-9. PubMed ID: 9635576
[TBL] [Abstract][Full Text] [Related]
24. The contribution of tandem repeat number to the O-glycosylation of mucins.
Silverman HS; Sutton-Smith M; McDermott K; Heal P; Leir SH; Morris HR; Hollingsworth MA; Dell A; Harris A
Glycobiology; 2003 Apr; 13(4):265-77. PubMed ID: 12626424
[TBL] [Abstract][Full Text] [Related]
25. Immune recognition of linear epitopes in peptide fragments of epithelial mucins.
Briggs S; Price MR; Tendler SJ
Immunology; 1991 Aug; 73(4):505-7. PubMed ID: 1717370
[TBL] [Abstract][Full Text] [Related]
26. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
Ho SB; Ewing SL; Montgomery CK; Kim YS
Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
[TBL] [Abstract][Full Text] [Related]
27. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
Apostolopoulos V; Xing PX; McKenzie IF
Cancer Res; 1994 Oct; 54(19):5186-93. PubMed ID: 7923138
[TBL] [Abstract][Full Text] [Related]
28. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC
Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230
[TBL] [Abstract][Full Text] [Related]
29. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
[TBL] [Abstract][Full Text] [Related]
30. Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells.
Yoon WH; Park HD; Lim K; Hwang BD
Biochem Biophys Res Commun; 1996 May; 222(3):694-9. PubMed ID: 8651907
[TBL] [Abstract][Full Text] [Related]
31. Polypeptide core of a human pancreatic tumor mucin antigen.
Lan MS; Hollingsworth MA; Metzgar RS
Cancer Res; 1990 May; 50(10):2997-3001. PubMed ID: 2334903
[TBL] [Abstract][Full Text] [Related]
32. Binding of tumor antigen mucin (MUC1) derived peptides to the heat shock protein DnaK.
Schreiber J; Stahn R; Schenk JA; Karsten U; Pecher G
Anticancer Res; 2000; 20(5A):3093-8. PubMed ID: 11062727
[TBL] [Abstract][Full Text] [Related]
33. Human B-cell immune response to the polymorphic epithelial mucin.
Rughetti A; Turchi V; Ghetti CA; Scambia G; Panici PB; Roncucci G; Mancuso S; Frati L; Nuti M
Cancer Res; 1993 Jun; 53(11):2457-9. PubMed ID: 8495404
[TBL] [Abstract][Full Text] [Related]
34. Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.
Fontenot JD; Tjandra N; Bu D; Ho C; Montelaro RC; Finn OJ
Cancer Res; 1993 Nov; 53(22):5386-94. PubMed ID: 8221676
[TBL] [Abstract][Full Text] [Related]
35. Breast mucin and associated antigens in diagnosis and therapy.
Peterson JA; Ceriani RL
Adv Exp Med Biol; 1994; 353():1-8. PubMed ID: 7527177
[No Abstract] [Full Text] [Related]
36. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.
Osinaga E; Pancino G; Porchet N; Berois N; De Cremoux P; Mistro D; Aubert JP; Calvo F; Roseto A
Breast Cancer Res Treat; 1994; 32(2):139-52. PubMed ID: 7532464
[TBL] [Abstract][Full Text] [Related]
37. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin.
Burchell J; Gendler S; Taylor-Papadimitriou J; Girling A; Lewis A; Millis R; Lamport D
Cancer Res; 1987 Oct; 47(20):5476-82. PubMed ID: 2443241
[TBL] [Abstract][Full Text] [Related]
39. MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation.
Hanisch FG; Stadie TR; Deutzmann F; Peter-Katalinic J
Eur J Biochem; 1996 Feb; 236(1):318-27. PubMed ID: 8617281
[TBL] [Abstract][Full Text] [Related]
40. Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain.
Kalra AV; Campbell RB
Br J Cancer; 2007 Oct; 97(7):910-8. PubMed ID: 17912239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
